Etiology and treatment of achalasia in the pediatric age group

V M Piñeiro-Carrero1, C A Sullivan, P L Rogers

  • 1Division of Pediatric Gastroenterology and Nutrition, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814-4799, USA. vpineiro@usuhs.mie

Insights

Pneumatic dilation is the primary definitive therapy for pediatric achalasia, offering safe and effective treatment. Heller myotomy serves as a safe surgical option for cases unresponsive to dilation.

Area of Science:

  • Pediatric Gastroenterology
  • Esophageal Motility Disorders

Background:

  • Achalasia in children shares clinical features and therapeutic approaches with adult cases.
  • Pharmacologic treatments offer only temporary symptom relief in pediatric achalasia.
  • Botulinum toxin injections provide short-term, safe symptom palliation.

Purpose of the Study:

  • To review the safety and effectiveness of pneumatic dilation for pediatric achalasia.
  • To establish pneumatic dilation as the primary definitive therapy for achalasia in children.
  • To identify effective alternative treatments for refractory pediatric achalasia.

Main Methods:

  • Review of safety and effectiveness data for pneumatic dilation in pediatric achalasia.
  • Evaluation of outcomes for graduated pneumatic dilation protocols.
  • Assessment of Heller myotomy as a secondary treatment option.

Main Results:

  • Pneumatic dilation is a safe and effective definitive therapy for pediatric achalasia.
  • Graduated pneumatic dilation achieves satisfactory results in most pediatric patients.
  • Heller myotomy is a safe and effective surgical treatment for children who do not respond to pneumatic dilation.

Conclusions:

  • Pneumatic dilation should be considered the primary definitive treatment for pediatric achalasia.
  • Heller myotomy is a viable and effective surgical option for refractory pediatric achalasia cases.

Related Concept Videos

Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
Pyloric Obstruction01:11

Pyloric Obstruction

Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...